Clinical Trials Directory

Trials / Completed

CompletedNCT00069615

Pilot Study of the GlucoWatch G2 Biographer for the Management of Type 1 Diabetes in Children

DirecNet Pilot Study to Evaluate the GlucoWatch G2 Biographer in the Management of Type 1 Diabetes in Children

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
15 (planned)
Sponsor
Jaeb Center for Health Research · Academic / Other
Sex
All
Age
7 Years – 17 Years
Healthy volunteers
Accepted

Summary

Devices such as the GlucoWatch G2 Biographer (GW2B), which constantly measure blood sugar levels, may improve the treatment of Type 1 diabetes mellitus in children. This study evaluated the GW2B when used by children in their homes.

Detailed description

The proper role of the GW2B in the management of Type 1 diabetes in children has not been determined. As a prelude to a large-scale randomized clinical trial (RCT) to compare the effect on glycemic control, hypoglycemia, and quality of life of using a GW2B versus standard care, the DirecNet Study Group conducted a pilot study to assess the feasibility of the protocol planned for the RCT and to collect data on changes in HbA1c, frequency of hypoglycemia, frequency of skin reactions, and quality of life after using the GW2B for three months. Fifteen children and adolescents with Type 1 diabetes participated in this study. Each patient was provided with a personal computer for weekly downloading of the GW2B and for completion of questionnaires regarding hypoglycemia and GW2B use. Participants received study telephone calls after 1, 2, and 4 weeks and every 4 weeks thereafter to review their diabetes management. Participants had a follow-up visit at Week 29. The Continuous Glucose Monitoring System was inserted at this visit to assess hypoglycemia over three days. A follow-up visit was performed at Week 30 to measure HbA1c and administer psychosocial questionnaires.

Conditions

Interventions

TypeNameDescription
DEVICEGlucoWatch® G2™ Biographer (GW2B)
DEVICEContinuous Glucose Monitoring System™ (CGMS)

Timeline

Start date
2003-02-01
Completion
2003-06-01
First posted
2003-09-30
Last updated
2016-09-05

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00069615. Inclusion in this directory is not an endorsement.